Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD22
114 Products
114 Products
740 Diseases
2772 News
1
2
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
7
14
21
28
35
42
49
56
63
70
Besponsa
(inotuzumab ozogamicin) / Pfizer, UCB
Epratucyn
(epratuzumab) / Gilead
Lumoxiti
(moxetumomab pasudotox) / AstraZeneca
LymphoCide Y-90
(epratuzumab Y-90) / Gilead
4SCAR-T
/ SZGIMI
BL-22
/ AstraZeneca
CTA101
/ Nanjing Bioheng Biotech
anti-CD19/CD22 CAR-T cells
/ Hrain Biotech
CART22
/ University of Pennsylvania
GC022F
/ AstraZeneca
Senl_22
/ SenlangBio
Senl_H19x22P
/ SenlangBio
firicabtagene autoleucel
(CRG-022) / CARGO Therap
suciraslimab
(SM03) / SinoMab
CD19-CD22 CAR-T
/ Shanghai Ultra-T Immune Therap
HY004
/ Juventas Cell Therapy
AUTO3
/ Autolus
Anti-CD22 CAR-T Cells
/ Beijing Boren Hospital
CART-19/22
/ Shanghai Unicar
CD19 and CD22 targeted prime CAR-T
/ Chongqing Precision Biotech
CD19/CD22 CAR T-cells
/ National Cancer Institute
CD19/CD22 CAR-T cell therapy
/ Shanghai Yake Biotech
CD19/CD22 chimeric antigen receptor T cell
/ Kecellitics Biotech
CT120
/ IASO BIO
Combotox
(Imtox19/Imtox22) / Montefiore Medical Center, National Cancer Institute, Abiogen
IMJ995
/ Novartis
LB1909
/ Legend Biotech
LCAR-AIO
/ Legend Biotech
OXS-1550
/ GT Biopharma
ThisCART22
/ Fundamenta Therap
UCART22
/ Cellectis
anti-CD22 CAR T
/ National Cancer Institute
multi-target gene-modified CAR-T/TCR-T cell immunotherapy
/ Shenzhen BinDeBio
pinatuzumab vedotin
(RG7593) / Roche
rezetamig
(JNJ-8780) / J&J
sequential different B cell antigen-targeted CAR T-cell therapy
/ Beijing Boren Hospital
4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR
/ SZGIMI
AUTO1/22
/ Autolus
Anti-CD19/CD20/CD22 CAR T-Cells
/ The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Instit
Anti-CD22 CAR NK Cells
/ Allife Medical Science and Technology
CAR-T CD19/CD20/CD22/CD30
/ Shanghai Unicar
CAR-T19/CAR-T22 immunotherapy
/ Shenzhen BinDeBio
CAR20.19.22 T
/ Miltenyi Biotec, Medical College of Wisconsin
CART22
/ Academy of Military Medical Sciences
CART2219.1
/ KK Women's and Children's Hospital
CD19/CD20/CD22 CAR-T
/ Xuzhou Medical University
CD19/CD22 dual target CAR T
/ Beijing Boren Hospital
CD19/CD22 dual-target CAR-T
/ Shenzhen University General Hospital
CD19x22 CAR T
/ University of Colorado
CD22-targeted CAR-T cell therapy
/ PersonGen Biomedicine
1
2
»
